RAMPAGE: The FDA aggressive activity

Aggressive "Desk Clearing" FDA approvals have already been fueling some of the easiest profits of 2021…

New studies conducted by researchers from Harvard University and MIT have concluded:

"The U.S. Food and Drug Administration is approving drugs faster than ever."

The report notes…

"Approval spikes occur at the end of each calendar month" and before the "end of the year in a kind of 'desk-clearing' activity."

Dozens of stocks could pop in the next 61 days as the FDA clears their backlog of drug approvals.

It all starts with one single ticker being announced in an Emergency Briefing…

Everyone who attends will leave with the single stock ticker that is expected to be in the best position to thrive from the FDA's latest decision.

All the best, *WealthPress*

Disclaimer & Disclosures The information in this email is intended for informational purposes only and does not guarantee specific results as there is a high degree of risk involved with trading. Also, our traders are real traders and may have financial interests in the companies discussed. Please see our Terms and Conditions for more information. WealthPress

This email was sent to penunggangbadai.moneyblog@blogger.com by WealthPress LLC